Venus Concept Inc.
venusconcept.comNo Longer Reporting
The company has not filed an annual or quarterly report since its Q3 FY2025 10-Q, filed Nov 13, 2025. Its latest SEC filing is a D from Apr 9, 2026.
10-Q for Q3 FY2025, filed Nov 13, 2025
The sections below describe the company as of the FY2024 annual report.
What Did They Do?
Develops and sells minimally invasive and non-invasive medical aesthetic systems and hair-restoration technologies to medical practices and aesthetic medical spas.
10-K for FY2024, filed Mar 31, 2025
How Did They Make Money?
Medical practices buy aesthetic systems through traditional sales or internal financing; financed purchases start with an upfront fee and continue with monthly payments, typically over 36 months. Customers also buy procedure kits, supplies and consumables, and existing customers can buy extended-warranty contracts.
10-K for FY2024, filed Mar 31, 2025The Company generates revenue from (1) sales of systems through our internal financing programs, in accordance with ASC 842, "Leases" ("ASC…View ↗
Many of the Company’s products are sold under our Venus Prime program and legacy subscription model, with unencumbered title passing to the…View ↗
Like our legacy subscription model, Venus Prime includes an up-front fee and a monthly payment schedule, typically over a period of 36…View ↗
Service revenue includes revenue derived from our extended warranty service contracts provided to our existing customers.View ↗
-
10-K for FY2024, filed Mar 31, 2025
FY2024 revenue by product or service ↗
$64.8M
-
10-K for FY2024, filed Mar 31, 2025
$64.8M ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Leases
Recurring
10-K for FY2024, filed Mar 31, 2025 |
20%
FY2021: 43%
|
Leases, FY2024
$13.3M Sources
|
Recurring |
|
System
Sold outright
10-K for FY2024, filed Mar 31, 2025 |
59%
FY2021: 41%
|
System, FY2024
$38M Sources
|
Sold outright |
|
Product
Sold outright
10-K for FY2024, filed Mar 31, 2025 |
16%
FY2021: 13%
|
Product, FY2024
$10.5M Sources
|
Sold outright |
|
Service
Recurring
|
4.8%
FY2021: 4.0%
|
Service, FY2024
$3.1M Sources
|
Recurring |
Who Were Their Customers?
Medical aesthetic practices—including plastic surgeons, dermatologists, general and family practitioners—and aesthetic medical spas buy the company's systems and related products. Venus sells directly in the United States and select international markets, and through distributors in countries where it does not operate directly.
10-K for FY2024, filed Mar 31, 2025We market and sell our products and services to the traditional medical aesthetic market including plastic surgeons and dermatologists, as…View ↗
In the United States and select international markets, we use our direct sales force to sell our systems and other products and services.…View ↗
In countries where we do not operate directly, we sell our products through distributors. As of December 31, 2024, we had distribution…View ↗
Did Revenues Turn Into Profits?
No. It lost $47M in FY2024.
10-K for FY2024, filed Mar 31, 2025
−$27.2MView ↗
10-K for FY2024, filed Mar 31, 2025
−$47MView ↗
10-K for FY2024, filed Mar 31, 2025
−$11.2MView ↗
How Were They Changing?
- Net income
-
Sources
10-Q for Q3 FY2025, filed Nov 13, 2025
−$22.6MView ↗
- ▲ +143% (Loss)
- vs −$9.3M in Q3 FY2024
10-Q for Q3 FY2025, filed Nov 13, 2025
Open tableView ↗
-
Jan 21, 2026
Plans voluntary Nasdaq delisting and SEC deregistration
The company expected Nasdaq trading to end and its periodic reporting duties to be suspended after filing the required forms.
Sources
8-K, filed Jan 21, 2026
On January 20, 2026, the Board of Directors of the Company approved a plan to voluntarily delist the Company’s common stock from the Nasdaq…View ↗
-
Nov 13, 2025
Agreed to sell its hair-restoration business
The company said closing had been delayed by challenges with the buyer and that it had sought court assistance to complete the transaction.
Sources
8-K, filed Nov 13, 2025
Mr. De Silva continued: “Since we announced a definitive agreement to sell our Venus Hair Business to MHG Co. Ltd. on June 6, 2025, we have…View ↗
Shrank. Revenue fell 17% in 4 years, from $78M in FY2020 to $64.8M in FY2024, about 5% a year.
Financing model
The older report centered on subscription-based system sales. The latest report describes reducing reliance on subscriptions in the United States and replacing the legacy subscription program with Venus Prime, an in-house financing plan.
10-K for FY2021, filed Mar 28, 2022 10-K for FY2024, filed Mar 31, 2025
Loading...
